Welcome to Multibagg AI
Log in to access personalized features
Home
Dashboard
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Bearish
4
Neutral
6
Bullish
4
Bearish
33
Neutral
6
Bullish
7
Bearish
29
Neutral
0
Bullish
3
Discovery themes featuring this stock
Emmessar Biotech & Nutrition Limited, originally Emmessar Chemical Industries Ltd, specializes in manufacturing specialty fine chemicals and biotech solutions.
The company transitioned into healthcare and biotechnology after realizing their chemicals' potential as 'Vital Micro Nutrients', significantly expanding its business scope.
A strategic partnership with Vibrant Life in 1998 enabled EBNL to introduce innovative products like VedaCeuticals, blending Nutraceuticals, Cosmeceuticals, Ayurveda, and Nanotechnology.
EBNL's products target unmet needs in healthcare, addressing chronic physical ailments and problematic skin, muscle, and bone issues.
The company's recognized R&D capabilities and international partnerships have led to significant product innovations and market expansion.
Chemicals
Chemicals - Speciality - Medium / Small
12 Cr
Low Risk
39.2
24.4
—
1.5
42.90
24.24
Sales CAGR
Profit CAGR
ROE
ROCE
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
| Symbol | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
1.06 | 21 Cr | -0.82 | 0.03 | 0.00 | -3.46 | -3.30 | -1.86 | |
62.50 | 19 Cr | -16.94 | 0.91 | 0.00 | -5.87 | -2.27 | -3.69 | |
18.18 | 17 Cr | -5.68 | 0.00 | 0.00 | -169.05 | -20.32 | -15.33 | |
33.45 | 13 Cr | 13.02 | 0.86 | 0.00 | 7.81 | 11.27 | 3.44 | |
41.48 | 13 Cr | -9.06 | 1.26 | 0.00 | -11.67 | -0.07 | -4.33 | |
25.10 | 12 Cr | 39.22 | 1.54 | 0.00 | 2.92 | 8.87 | 3.47 | |
4.59 | 9 Cr | 0.25 | 0.00 | 0.00 | 7.37 | -11.97 | -18.32 |
Emmessar Biotech & Nutrition Ltd (EMMESSA) is currently trading at 25.10 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Emmessar Biotech & Nutrition Limited, originally Emmessar Chemical Industries Ltd, specializes in manufacturing specialty fine chemicals and biotech solutions. The company transitioned into healthcare and biotechnology after realizing their chemicals' potential as 'Vital Micro Nutrients', significantly expanding its business scope. A strategic partnership with Vibrant Life in 1998 enabled EBNL to introduce innovative products like VedaCeuticals, blending Nutraceuticals, Cosmeceuticals, Ayurveda, and Nanotechnology. EBNL's products target unmet needs in healthcare, addressing chronic physical ailments and problematic skin, muscle, and bone issues. The company's recognized R&D capabilities and international partnerships have led to significant product innovations and market expansion.
Over the past 52 weeks, Emmessar Biotech & Nutrition Ltd has traded between a low of ₹24.24 and a high of ₹42.90. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Emmessar Biotech & Nutrition Ltd has a market capitalization of approximately 12.28. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Emmessar Biotech & Nutrition Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 39.22 and operates in the Chemicals sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 12.28 Cr, Emmessar Biotech & Nutrition Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Emmessar Biotech & Nutrition Ltd operates in the Chemicals sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Emmessar Biotech & Nutrition Ltd is 39.22. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
